Smartwatch activity tracking for fatigue after chemo
Part of Cancer, Digestive system, Hormones & metabolism, Skin clinical trials.
This study uses a smartwatch to track your physical activity and see if it helps reduce tiredness after finishing chemotherapy. It is for people who finished treatment for certain cancers less than 3 months ago.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have had breast, colorectal, ovarian, pancreatic, bile duct, or stomach cancer that has not spread.
- You finished your chemotherapy (not including hormone therapy) less than 3 months ago.
- You are able to be up and about, with at most some limits on strenuous activity.
- You have no new cancer treatments planned (except hormone therapy) and no heart condition that would make exercise unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a wearable device (WATD) can help track and improve fatigue in people with pancreatic or breast cancer who are receiving treatment. The goal is to find better ways to manage treatment-related tiredness.
This study tests whether using a wearable device and a smartphone app can help you get fitter before and after your surgery for pancreatic cancer. The goal is to see if this program improves your recovery and overall well-being.
This study looks at how your daily step count, measured by a smartwatch, relates to how well your breast cancer responds to treatment before surgery. It may help show if being more active during chemotherapy leads to better outcomes.
This study tests whether people treated for brain tumors can safely use a tailored exercise program tracked by a smartwatch. The goal is to see if gentle, adapted physical activity helps manage side effects like weakness, memory problems, or concentration difficulties.
This study tests whether wearing a smartwatch and using an app can help doctors better manage pain and other symptoms in advanced cancer patients. The goal is to catch problems early and improve comfort through better symptom tracking.
This study tests whether using a wearable watch and smartphone app to track activity and fitness can help monitor health in people with hormone receptor–positive, HER2-negative metastatic breast cancer while they take standard hormone therapy plus palbociclib. It mainly requires that you are already on these medicines for at least three months and can use the devices reliably.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.